University of East Anglia and King’s College London release guidance for GPs managing patients using…
New recommendations aim to support primary care professionals as private use of GLP-1 medications such as Mounjaro and Ozempic…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Latest Updates
Lupin launches Prucalopride Tablets in the US market post FDA approval
Lupin begins US sales of Prucalopride Tablets, bioequivalent to Takeda’s Motegrity, for chronic idiopathic constipation treatment
Sudeep Pharma files DRHP with SEBI for IPO to raise ₹95 Crore
The company files DRHP with SEBI to raise funds via IPO
Bharat Biotech and GSK pledge to lower malaria vaccine price under Gavi replenishment initiative
RTS,S vaccine price to be reduced to below $5 by 2028 through manufacturing scale-up and technology transfer
Lupin receives approval from US FDA for Prucalopride Tablets
The approved tablets are bioequivalent to Takeda’s Motegrity and will be manufactured at Lupin’s Goa facility
Yeztugo holds potential to address key unmet needs for PrEP usage including adherence issues:…
Twice-yearly injectable therapy may improve adherence and expand access to HIV prevention, but affordability and insurance…
Utopia Therapeutics secures $1.5 million seed funding from whale tank to advance obesity vaccine…
Investment will accelerate preclinical development of UT009 and support early-stage trials for novel immunotherapeutic targeting…
Novo Nordisk launches Wegovy for chronic weight management and cardiovascular risk reduction in…
Wegovy, a once-weekly semaglutide injection, is reportedly the first GLP-1 receptor agonist in India approved for both long-term…
CNS innovator oligonucleotide licensing value surges by 339% to $2.8 billion in 2024, reveals…
GlobalData attributes surge in CNS oligonucleotide licensing to increased adoption of ASOs and siRNAs, alongside advancements in…
Rubicon Research acquires Alkem’s Pithampur manufacturing facility for ₹149 crores
The acquisition expands Rubicon’s manufacturing footprint and capabilities in high-potency formulations, supporting its US market…
Glenmark launches TEVIMBRA in India for treatment of advanced lung and oesophageal cancer
Glenmark Pharmaceuticals introduces tislelizumab following CDSCO approval, expanding its oncology portfolio with its first…
CORONA Remedies appoints four independent directors to strengthen board governance
Ameetkumar H Desai, Bhaskar V Iyer, Shirish G Belapure, and Monica H Kanuga join CORONA Remedies’ Board as Independent Directors…
Why most extractables & leachables studies fail regulatory review-and how to fix them
Madhu of SG Pharma Solutions highlights why extractables and leachables (E&L) studies frequently fail regulatory review and…
CII to host ‘Pillars of Protection’ conference in Hyderabad to address safety in pharma…
The event will highlight collaborative approaches to risk management, compliance, and technology integration for safer…
Eli Lilly shares results from QWINT trials on once-weekly insulin efsitora for type 2 diabetes
Efsitora met primary endpoints across three Phase 3 trials, showing comparable glucose control to daily basal insulin therapies
Addressing US FDA challenges in Indian sterile drug manufacturing – Part 3
In this final instalment, Manish Bhatkar, Founder & CEO, RedLotus Pharmtech, transitions from analysis to action. Drawing on…
Addressing US FDA challenges in Indian sterile drug manufacturing – Part 2
In this second part, Manish Bhatkar, Founder & CEO, RedLotus Pharmtech continues the discussion on FDA expectations, with…
Biopharma innovation meets market headwinds tempering optimism: GlobalData
GlobalData’s report captures a moment for the global biopharmaceutical sector, where the pace of innovation is clashing with a…
Addressing US FDA challenges in Indian sterile drug manufacturing – Part 1
In the three-part series, Manish Bhatkar, Founder & CEO, RedLotus Pharmtech in this article explores the evolution of India’s…
Abbott and MSD Pharmaceuticals partner to distribute oral anti-diabetic medicines in India
Through this agreement, Abbott will distribute MSD’s Januvia, Janumet, and Janumet XR across India to support diabetes management…